William Blair Investment Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-42,861
Closed -$3.53M 356
2020
Q1
$3.53M Sell
42,861
-6,967
-14% -$622K 0.02% 312
2019
Q4
$4.72M Buy
49,828
+246
+0.5% +$22.1K 0.02% 322
2019
Q3
$4.31M Sell
49,582
-16,764
-25% -$1.51M 0.02% 321
2019
Q2
$6.06M Buy
66,346
+11,511
+21% +$974K 0.03% 325
2019
Q1
$4.72M Buy
54,835
+12,756
+30% +$1.02M 0.02% 343
2018
Q4
$3.23M Buy
+42,079
New +$3.28M 0.02% 353
2018
Q2
Sell
-59,478
Closed -$4.31M 496
2018
Q1
$4.31M Sell
59,478
-13,340
-18% -$1.02M 0.02% 360
2017
Q4
$5.48M Buy
72,818
+19,127
+36% +$1.44M 0.02% 340
2017
Q3
$4.13M Buy
53,691
+8,274
+18% +$625K 0.01% 363
2017
Q2
$3.4M Buy
45,417
+100
+0.2% +$7.09K 0.01% 373
2017
Q1
$3.02M Buy
45,317
+2,515
+6% +$168K 0.01% 379
2016
Q4
$2.79M Buy
42,802
+10,716
+33% +$695K 0.01% 374
2016
Q3
$2.27M Sell
32,086
-23,080
-42% -$1.68M 0.01% 384
2016
Q2
$4.08M Sell
55,166
-1,850
-3% -$128K 0.02% 367
2016
Q1
$3.7M Buy
57,016
+322
+0.6% +$21.9K 0.01% 368
2015
Q4
$4.37M Buy
56,694
+16,733
+42% +$1.33M 0.02% 363
2015
Q3
$3.29M Buy
+39,961
New +$3.56M 0.01% 830

Other funds holding NVS

William Blair Investment Management's NVS Position: Q2 2020 in Review

William Blair Investment Management sold out of Novartis (NVS) in Q2 2020, closing a stake of 42,861 shares — an estimated $3.53M sold.

William Blair Investment Management first reported a position in NVS in Q3 2015 and held it in 17 quarters. The position peaked at $6.06M in Q2 2019. 1,129 funds tracked by Wall St. Rank hold NVS as of Q2 2020.

  • William Blair Investment Management reported no remaining Novartis position as of Q2 2020 after selling out during the quarter.
  • William Blair Investment Management sold 42,861 Novartis shares in Q2 2020, an estimated $3.53M.
  • William Blair Investment Management first reported a position in Novartis in Q3 2015 and held it in 17 quarters.
  • William Blair Investment Management's Novartis position peaked at $6.06M in Q2 2019.
  • 1,129 funds tracked by Wall St. Rank held Novartis as of Q2 2020.

Based on William Blair Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.